Screener
Indivior Pharmaceuticals, Inc. INDV Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Other current and noncurrent assets | (18) | (18) |
| Accrued legal and settlement expenses | (38) | (62) |
| Other current and noncurrent liabilities | (86) | 81 |
| Net cash (used in) provided by operating activities | (9) | 75 |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (20) | (5) |
| Purchases of investments in debt securities | (5) | (5) |
| Sales and maturities of debt securities | 6 | 6 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s operating cash flow?
- Indivior Pharmaceuticals, Inc. (INDV) reported operating cash flow of -$9M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s operating cash flow decreased by 112.0% year-over-year, from $75M to -$9M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s operating cash flow?
- Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s operating cash flow has grown at a 159.8% compound annual growth rate (CAGR), from -$4M to -$27M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Indivior Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude